Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12018016
APP PUB NO 20230133406A1
SERIAL NO

17820271

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (A) are provided which are useful in the treatment of diseases or conditions modulated at least in part by CCR6:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • AMGEN INC.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Harland, Aubrie Redwood City, US 3 2
Krasinski, Antoni Sunnyvale, US 43 409
Lange, Christopher W Hayward, US 32 113
Lui, Rebecca M Mountain View, US 50 168
Marshall, Daniel R San Mateo, US 32 815
Roth, Howard S Sunnyvale, US 16 99
Yang, Ju Palo Alto, US 72 605
Zhang, Penglie Foster City, US 164 1806

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 25, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 25, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 25, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00